by S Zhang 2024 Cited by 3Nonalcoholic fatty liver disease (NAFLD) is the liver component of a cluster Rosuvastatin treatment attenuated hepatic steatosis in NAFLD mice by modulating
Rosuvastatin works by blocking an enzyme in the liver called slow the buildup of fatty deposits (plaque) in the walls of blood vessels.
No medications are currently approved for the treatment of fatty liver disease. What is the main cause of fatty liver? Fatty liver disease has two types: alcoholic fatty liver disease and NAFLD.
It goes by many names: non-alcoholic steatohepatitis (NASH), fatty liver, non-alcoholic fatty liver disease (NAFLD). fatty liver, ibuprofen
by TS AlGhamdi 2024 Cited by 2Non-alcoholic fatty liver disease (NAFLD) commonly causes an in- simvastatin, rosuvastatin, pravastatin, pitavastatin. safety
by B LIU 2024Objective To investigate the efficacy of rosuvastatin combined with silibinin capsule in treatment of hyperlipidemic patients with nonalcoholic fatty liver
by W Zhu 2024 Cited by 13with rosuvastatin on the intestinal flora, lipid metabolism, liver function and inflammation in patients with nonalcoholic fatty liver
Liver biopsy is the gold standard of assessing fatty liver but present study used ultrasonographic imaging studies for assessing grades of fatty liver which is another limitation of this study. 5. Conclusion. Rosuvastatin in addition to the hypocaloric diet might be an effective alternative treatment for hepatic steatosis.
liver disease liver cancer fatty liver hepatitis liver cirrhosis alcoholic hepatitis fatty liver diet nonalcoholic fatty liver disease cirrhosis
I can say when I submitted chapter 5 I immediately had some inspiration for chapter 6 and I hope that goes somewhere soon.